–
Статьи в журналах
-
- 2021 Phase I trial of 99mTc-(HE)3-G3, a DARPin-based probe for imaging of HER2 expression in breast cancer
- Bragina O., Chernov V., Schulga A., Konovalova E., Garbukov E., Vorobyeva A., Orlova A., Tashireva L., Sorensen J., Zelchan R., Medvedeva A., Deyev S., Tolmachev V.
- в журнале Journal of Nuclear Medicine, издательство Kexue Chubaneshe/Science Press (China) DOI